[1]Shoji F,Morodomi Y,Akamine T,et al.Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer[J].Lung Cancer,2016,98:15-21.
[2]Kos FT,Hocazade C,Kos M,et al.Assessment of prognostic value of "neutrophil to lymphocyte ratio" and "prognostic nutritional index" as a sytemic inflammatory marker in non-small cell lung cancer[J].Asian Pac J Cancer Prev,2015,16(9):3997-4002.
[3]Shimizu K,Okita R,Saisho S,et al.Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer[J].World J Surg Oncol,2015,13:291.
[4]Qiu C,Qu X,Shen H,et al.Evaluation of prognostic nutritional index in patients undergoing radical surgery with non small cell lung cancer[J].Nutr Cancer,2015,67(5):741-747.
[5]Chen SW,Xiao XR,Luo JM.Effect of early enterai nutrition combined with thymosin alpha-1 on patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure[J].Parenteral & Enteral Nutrition,2017,24(6):332-335.[陈思伟,肖小荣,罗金明.慢性阻塞性肺病急性加重合并呼吸衰竭病人早期肠内营养联合胸腺肽α1的疗效观察[J].肠外与肠内营养,2017,24(6):332-335.]
[6]Guo JY,Fang LJ,Guo JY.Correlation analysis between prognostic nutritional index and clinical features and prognosis of resectable gastric cancer[J].Chinese Journal of Clinical Oncology,2015,42(2):100-104.[郭加友,方立俭,郭嘉漪.预后营养指数与胃癌术后临床特征及预后关系[J].中国肿瘤临床,2015,42(2):100-104.]
[7]Zhang M,Yoshizawa A,Kawakami S,et al.The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema[J].Cancer Med,2016,5(10):2721-2730.
[8]Tomita M,Ayabe T,Chosa E,et al.Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer[J].Anticancer Res,2014,34(6):3137-3140.
[9]Yotsukura M,Ohtsuka T,Kaseda K,et al.Value of the Glasgow prognostic score as a prognostic factor in resectable non-small cell lung cancer[J].J Thorac Oncol,2016,11(8):1311-1318.
[10]Akamine T,Takada K,Toyokawa G,et al.Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer:A comprehensive analysis of systemic inflammatory markers[J].Surg Oncol,2018,27(1):88-94.
[11]Li SQ,Jiang YH,Lin J,et al.Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals[J].Cancer Med,2018,7(4):1221-1231.
[12]Minami S,Ogata Y,Ihara S,et al.Neutrophil-to-lymphocyte ratio predicts overall survival of advanced non-small cell lung cancer harboring mutant epidermal growth factor receptor[J].World J Oncol,2017,8(6):180-187.
[13]Zhang YF,Niu CL,Li JL,et al.Prognostic values of preoperative neutrophil-lymphocyte ratio and Glasgow prognostic score in non-small cell lung cancer patients[J].Modern Oncology,2016,24(8):1221-1223.[张艳芳,牛春莲,李江丽,等.术前中性粒细胞/淋巴细胞比值和Glasgow评分对非小细胞肺癌预后的影响[J].现代肿瘤医学,2016,24(8):1221-1223.]
[14]Sim SH,Beom SH,Ahn YO,et al.Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors[J].Thorac Cancer,2016,7(2):161-166.
[15]Tomita M,Ayabe T,Maeda R,et al.Combination of advanced lung cancer inflammation index and C-reactive protein is a prognostic factor in patients with operable non-small cell lung cancer[J].World J Oncol,2017,8(6):175-179.
[16]Fu YL,Wu YH.Effect of synchronous nutritional intervention on inflammatory response and prognosis of patients with gastrointestinal cancer after operation[J].Chinese Journal of Modern Nursing,2014,20(1):62-65.[傅亚玲,吴燕红.同步营养干预对胃肠道肿瘤患者术后炎症反应和预后的影响[J].中华现代护理杂志,2014,20(1):62-65.]
[17]Zhang Y,Chen FL.Relationship between the inflammatory-nutritional index and recurrence and prognosis in patients with gastric cancer[J].The Journal of Practical Medicine,2015,31(6):936-939.[张杨,陈佛来.炎症营养指数与胃癌术后复发和预后的关系[J].实用医学杂志,2015,31(6):936-939.]
[18]Tong YS,Tan J,Zhou XL,et al.Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer[J].J Transl Med,2017,15(1):221.
[19]Wang H,Zhao J,Zhang M,et al.The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer[J].J Cell Physiol,2018,233(5):4216-4224.